Loading article...
FTC Signals Intensified Enforcement Across the Health Care and Life Sciences Industries | ArentFox Schiff
Afslaw.com
1 day ago
Neutral
The Federal Trade Commission (FTC) is signaling that health care and life sciences companies should expect heightened regulatory scrutiny related to consumer protection and competition.
On March 20, Chairman Andrew N. Ferguson issued a memorandum directing the FTCs Bureaus of Competition, Consumer Protection, and Economics, Office of Policy Planning, and Office of Technology staff t… [+8277 chars]
Continue reading on Afslaw.com
Read Full Article